The National Institute on Drug Abuse (NIDA) is offering this grant to invite clinical investigators to participate in its established National Drug Abuse Treatment Clinical Trials Network (CTN). This grant is specifically for enhancing the network’s crucial capacity to respond effectively to urgent public health needs related to substance use disorders. NIDA aims to continue its vital mission of developing and rigorously testing innovative interventions designed to address the comprehensive spectrum of substance use problems. This is achieved through fostering robust collaborative partnerships, uniting NIDA with skilled clinical research investigators, community representatives, dedicated healthcare providers, and key healthcare institutions within the CTN framework. The initiative focuses on advancing evidence-based treatments and strategies.
Opportunity ID: 350930
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-25-027 |
| Funding Opportunity Title: | The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 08, 2023 |
| Last Updated Date: | Nov 08, 2023 |
| Original Closing Date for Applications: | Mar 13, 2024 |
| Current Closing Date for Applications: | Mar 13, 2024 |
| Archive Date: | Apr 18, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities City or township governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education County governments Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts State governments For profit organizations other than small businesses Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Notice of Funding Opportunity (NOFO) invites applications from clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN) and contribute to the network’s capacity to respond to urgent public health needs. NIDA intends to continue to develop and test interventions for addressing the wide spectrum of substance use problems via collaborative partnerships among NIDA, clinical research investigators, community representatives, healthcare providers, and healthcare institutions. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-027.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 350930 Full Announcement-RFA-DA-25-027 -> RFA-DA-25-027-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00283751 | Feb 13, 2024 | Mar 13, 2024 | View |
Package 1
Mandatory forms
350930 RR_SF424_5_0-5.0.pdf
350930 PHS398_CoverPageSupplement_5_0-5.0.pdf
350930 RR_OtherProjectInfo_1_4-1.4.pdf
350930 PerformanceSite_4_0-4.0.pdf
350930 RR_KeyPersonExpanded_4_0-4.0.pdf
350930 RR_Budget10_3_0-3.0.pdf
350930 PHS398_ResearchPlan_5_0-5.0.pdf
350930 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
350930 RR_SubawardBudget10_30_3_0-3.0.pdf
350930 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
